10-Q: Neogen Reports Significant Net Loss Due to Goodwill Impairment in Q2 2025

Neogen Corporation's Q2 2025 results reveal a substantial net loss primarily driven by a $461.4 million goodwill impairment charge in its Food Safety segment.

Summary

• Neogen Corporation reported a net loss of $456.3 million for the three months ended November 30, 2024, compared to a net loss of $3.5 million for the same period in 2023.
• The significant increase in net loss is primarily attributed to a $461.4 million goodwill impairment charge within the Food Safety reporting unit.
• Revenue increased slightly to $231.3 million from $229.6 million in the prior year, with growth in food quality and nutritional analysis, indicator testing, and rodent control product lines.
• However, revenue was negatively impacted by production constraints in the sample collection product line and lower genomics volume.
• For the six months ended November 30, 2024, the net loss was $468.9 million compared to a net loss of $2.0 million in the prior year.
• Total revenues for the six-month period decreased to $448.2 million from $458.6 million in 2023.
• The company is implementing restructuring initiatives, including consolidation of facilities and rationalization of operations, with restructuring charges totaling $9.6 million for the quarter and $9.9 million for the six-month period.
• The company identified material weaknesses in internal control over financial reporting related to control activities and information and communication.
• The company is in the process of implementing measures to remediate these weaknesses.
• The company had cash and cash equivalents of $140.2 million as of November 30, 2024, and $150.0 million available under its revolving line of credit.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the significant net loss, goodwill impairment, and identified material weaknesses in internal control. While there are some positive aspects, such as slight revenue growth and available liquidity, the overall tone is concerning.

Positives

• Revenue increased slightly for the quarter, driven by growth in food quality and nutritional analysis, indicator testing, and rodent control product lines.
• The company has $140.2 million in cash and cash equivalents and $150.0 million available under its revolving line of credit.
• The company is actively addressing identified material weaknesses in internal control over financial reporting through remediation efforts.

Negatives

• The company reported a significant net loss of $456.3 million for the quarter, primarily due to a $461.4 million goodwill impairment charge.
• Revenue decreased for the six months ended November 30, 2024.
• The company identified material weaknesses in internal control over financial reporting.
• The company is incurring restructuring charges, indicating operational challenges.

Risks

• The company faces risks related to the continued integration of the 3M food safety business.
• The company faces risks related to the relationship with and performance of its transition manufacturing partner.
• The company faces risks related to its ability to adequately and timely remediate certain identified material weaknesses in its internal control over financial reporting.
• The company faces risks related to competition, recruitment and retention of key employees, and the impact of weather on agriculture and food production.
• The company faces risks related to global business disruption caused by the Russia invasion in Ukraine and related sanctions and the conflict in the Middle East.
• The company faces risks related to identification and integration of acquisitions, research and development, and intellectual property protection.
• The company faces risks related to increasing and developing government regulation.

Future Outlook

The company expects issues related to supply chain challenges, labor market disruptions, input cost inflation, softening consumer demand, higher interest rates, and geopolitical tensions to continue to impact it throughout fiscal year 2025. The company expects delays in restarting full production of its sample collection product line to be resolved and reach historical production levels in the second half of the fiscal year. The company is optimistic about future growth of revenue in the Animal Safety segment, particularly if the distribution channel begins to meaningfully restock inventory.

Management Comments

• Management is optimistic about the company's long-term prospects, but historical financial information may not be indicative of future financial results.
• Management believes that cash flows from operations, cash on hand, and borrowing capacity will enable the company to fund the operating business, repay debt obligations, construct new manufacturing facilities, commercialize products currently under development, and execute its strategic plans.

Industry Context

The Food Safety industry continues to have a resulting lower level of food production, partly due to significant inflation in food prices. However, there has been gradual end market improvement that has coincided with an increasing focus on food safety from both consumers and regulators. The Animal Safety industry is at or near cyclical lows in the end market.

Comparison to Industry Standards

• It is difficult to compare Neogen's results directly to industry standards without specific competitor data.
• However, the goodwill impairment suggests that the acquired assets from 3M may not be performing as initially expected compared to similar acquisitions in the food safety industry.
• The material weaknesses in internal control could be viewed negatively compared to companies with robust control environments, such as established players like Thermo Fisher Scientific or Danaher Corporation.

Stakeholder Impact

• Shareholders will be negatively impacted by the significant net loss and goodwill impairment.
• Employees may be impacted by the restructuring initiatives, including potential job losses.
• Customers may experience disruptions due to production constraints in the sample collection product line.
• Suppliers and creditors may be impacted by the company's financial performance and liquidity.

Next Steps

• The company will continue to implement measures to remediate the identified material weaknesses in internal control over financial reporting.
• The company will continue to monitor and forecast its liquidity situation and evaluate other financial alternatives that may be available.
• The company will continue to make investments in its business and operating facilities, with an estimated $85 million in capital expenditures planned for fiscal 2025.

Key Dates